Sigma receptors: Chemistry, cell biology and clinical implications

Sigma Receptors: Chemistry, Cell Biology and Clinical Implications

Volumn , Issue , 2007, Pages 1-413

  Matsumoto, Rae R ^a   Bowen, Wayne D ^b   Su, Tsung Ping ^c  

^a University of IVIississippi University IVIS   (United States)

^b BROWN UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84920051671     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-0-387-36514-5     Document Type: Book

References (43)

1. 3H]-DTG, a selective sigma receptor ligand, in the sheep pineal gland. Biochem Biophys Res Comm 1990, 171:875-881.
2. 3H]haloperidol in human and rat cerebellum. Naunyn-Schmiedeberg Arch Pharmacol 1992, 345:197-202.
3. 3H](+)-3-PPP to σ binding sites in rat brain. Neurosci Lett 1990, 116:190-193.
4. Craviso GL, Musacchio JM. High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments. Mol Pharmacol 1983, 23:629-640.
5. 3H]DuP 734 [l-(cyclopropylmethyl)-4- (2'-(4'-fluorophenyl)-2'-oxoethyl)-piperidine HBr]: A receptor ligand profile of a highaffinity novel sigma receptor ligand in guinea pig brain. J Pharmacol Exp Ther 1992, 263:1175-1187.
6. 3H]1, 3-(2- Tolyl)guanidine (DTG)-defined sigma recognition sites in guinea pig brain. Life Sci 1992, 50:PL65-70.
7. [3H](+)-pentazocine to a recognition sites in guinea pig brain. Eur J Pharmacol 1992, 227:371-378.
8. + channel of class III antiarrhythmic drugs? Eur J Pharmacol 1993, 241:111-116.
9. Klein M, Musacchio JM. High affinity dextromethorphan binding sites in guinea pig brain. Effect of sigma ligands and other agents. J Pharmacol Exp Ther 1989, 251:207- 215.
10. 3H]3-(3-hydroxyphenyl)-N-(l-propyl)piperidine. Proc Natl Acad Sci USA 1984, 81:4983-4987.
11. Samovilova NN, Nagornaya LV, Vinogradov VA. (+)-[3H]SK&F 10, 047 binding sites in rat liver. Eur J Pharmacol 1988, 147:259-264.
12. Su T-P. Evidence for sigma opioid receptor: Binding of f HJSKF-10047 to etorphinein accessible sites in guinea-pig brain. J Pharmacol Exp Ther 1982, 223:284-290.
13. Tam SW. Naloxone-inaccessible σ receptor in rat central nervous system. Proc Natl Acad Sci USA 1983, 80:6703-6707.
14. 3H]ethylketocyclazocine, μ, ?, δ and phencyclidine binding sites in guinea pig brain membranes. Eur J Pharmacol 1985, 109:33-41.
15. 3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81:5618-5621.
16. Tam SW, Mitchell KN. Neuropeptide Y and peptide YY do not bind to brain o and phencyclidine binding sites. Eur J Pharmacol 1991, 193:121-122.
17. 3H]tolyl)guanidine: A selective ligand that labels σ-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 1986, 83:8784-8788.
18. Yamada M, Nighigami T, Nakasho K, Nishimoto Y, Miyaji H. Relationship between sigma-like site and progesterone-binding site of adult male liver microsomes. Hepatology 1994, 20:1271-1280.
19. Hellewell SB, Bowen WD. A sigma-like binding site in rat pheochromocytoma (PCI2) cells: Decreased affinity for (+)-benzomorphans and lower molecular weight suggest a different sigma receptor form from that in guinea pig brain. Brain Res 1990, 527:244-253.
20. Yang ZW, Paleos GA, Byrd JC. Expression of (+)-3-PPP binding sites in the PC 12 pheochromocytoma cell line. Eur J Pharmacol 1989, 164:607-610.
21. Vilner, BJ, Bowen, WD. Characterization of sigma-like binding sites of NB41A3, S-20Y, and NlE-115 neuroblastomas, C6 glioma, and NG108-15 neuroblastoma-glioma hybrid cells: Further evidence for sigma-2 receptors. In: Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodutation and Neuroprotection? J.-M. Kamenka and E.F. Domino, eds. NPP Books, Ann Arbor, MI, 1992, pp. 341-353.
22. Vilner BJ, de Costa BR, Bowen WD. Cytotoxic effects of sigma ligands: Sigma receptor-mediated alterations in cellular morphology and viability. J Neurosci 1995, 15:117-134.
23. Vilner BJ, John CS, Bowen, WD. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res 1995, 55:408-413.
24. Georg A, Friedl A. Characterization of specific binding sites for [3H]-1, 3-di-otolylguanidine (DTG) in the rat glioma cell line C6-BU-1. Glia 1992, 6:258-263.
25. Barg J, Thomas GE, Bern WT, Parnes MD, Ho AM, Belcheva MM, McHale RJ, McLachlan JA, Tolman KC, Johnson FE, Coscia CJ. In vitro and in vivo expression of opioid and sigma receptors in rat C6 glioma and mouse N18TG2 neuroblastoma cells. J Neurochem 1994, 63:570-574.
26. Vilner BJ, Bowen WD. Modulation of cellular calcium by sigma-2 receptors: Release from intracellular stores in human SK-N-SH neuroblastoma cells. J Pharmacol Exp Ther 2000, 292:900-911.
27. Hong W, Nuwayhid SJ, Werling LL. Modulation of bradykinin-induced calcium changes in SH-SY5Y cells by neurosteroids and sigma receptor ligands via a shared mechanism. Synapse 2004, 54:102-110.
28. 2+ changes in SH-SY5Y cells. Eur J Pharmacol 2002, 436:35-45.
29. Ryan-Moro, J, Chien, CC, Standifer, KM, and Pasternak, GW. Neurochem Res 1996, 21:1309-1314.
30. Georg A, Friedl A. Identification and characterization of two sigma-like binding sites in the mouse neuroblastoma x rat glioma hybrid cell line NG108-15. J Pharmacol Exp Ther 1991, 259:479-483.
31. Wu XZ, Bell JA, Spivak CE, London ED, Su T-P. Electrophysiological and binding studies on intact NCB-20 cells suggest presence of a low affinity sigma receptor. J Pharmacol Exp Ther 1991, 257:351-359.
32. Al-Nabulsi I, Mach RH, Wang L-M, Wallen CA, Keng PC, Sten K, Childers SR, Wheeler KT. Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells. Brit J Cancer 1999, 81:925-933.
33. Crawford KW, Bowen WD. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res 2002, 62:313-322.
34. Mach RH, Smith CR, Al-Nabulsi I, Whirrett BR, Childers SR, Wheeler KT. Sigma-2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 1997, 57:156-161.
35. Colabufo NA, Berardi F, Contino M, Fazio F, Matarrese M, Moresco RM, Niso M, Perrone R, Tortorella V. Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET. J Pharm Pharmacol 2005, 57:1453-1459.
36. Ganapathy, ME, Prasad, PD, Huang, W, Seth, P, Leibach, FH, Ganapathy, V. Molecular and ligand-binding characterization of the sigma-receptor in the Jurkat human T lymphocyte cell line. J Pharmacol Exp Ther 1999, 289:251-260.
37. 3H]1, 3-(2- Tolyl)guanidine binds to a sigma-2 receptor on Jurkat cell membranes, but sigma compounds fail to influence immunomodulatory events in human peripheral blood lymphocytes. Immunopharmacol 1996, 35:27-39.
38. John CS, Bowen WD, Varma VM, McAfee JG, Moody TW. sigma receptors are expressed in human non-small cell lung carcinoma. Life Sci 1995, 56:2385-2392.
39. Wilke RA, Mehta RP, Lupardus PJ, Chen Y, Ruoho AE, Jackson MB. Sigma receptor photolabeling and sigma receptor-mediated modulation of potassium channels in tumor cells. J Biol Chem 1999, 274:18387-18392.
40. John CS, Bowen WD, Saga T, Kinuya S, Vilner BJ, Baumgold J, Paik CH, Reba RC, Neumann RD, Varma VM, McAfee JG. A malignant melanoma imaging agent: Synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2- piperidinylaminoethyl)4-iodobenzamide. J. Nucl. Med. 1993, 34:2169-2175.
41. John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD. Targeting sigma receptorbinding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors. Cancer Res 1999, 59:4578-4583.
42. Kekuda, R, Prasad, PD, Fei, YJ, Leibach, FH, and Ganapathy, V. Cloning and functional expression of the human type 1 sigma receptor (hSigmaRl). Biochem Biophys Res Commun 1996, 229:553-558.
43. +/peptide transporter PEPTl in the human intestinal cell line Caco-2. Biochem Biophys Res Commun 1999, 261:242-246.